- 5,947
It is always a business decision.
My point is, the 10% or 20% is roughly what it would cost to investigate and quite often less.
For instance, let's assume the annual premium was $1000 and the company was paying 20% on top and the person died a day before 2 years. So we'll round to $400 in addition to the return of premium. Well, what does one APS cost, maybe $50 to the doctor's office plus a fee to EMSI or whomever chases it down, so at least another $50 to them. What if you need more than one APS, what if it takes EMSI a long time to get it? You can easily spend that $400 on APSes. Plus the time employees spend reviewing it.
Now, you also get to chargeback commission for a rescission, which you may or may not for early death. Assuming it was 80%, then that is another $800. So you save $1,200 if you can deny the claim. But how much of that $1,200 will you spend to determine if you can deny it? How often will you be right? And how much damage will you do to your brand by investigating and denying ROP claims?
I am sure have a algorithm for this that has a geographic specific setting running in some dark closet somewhere that is hooked directly to the CFO's desk top.